Bausch + Lomb Corporation (BLCO) ist ein börsennotiertes Unternehmen im Gesundheitswesen Sektor, tätig in der Medical - Instruments & Supplies Branche. Der Hauptsitz des Unternehmens ist in Vaughan, ON, Canada. Der aktuelle CEO ist Brenton L. Saunders.
BLCO hat IPO-Datum 2022-05-06, 13,500 Vollzeitbeschäftigte, gelistet an der NYSE, eine Marktkapitalisierung von $5.92B.
Bausch + Lomb Corporation is a global eye health company founded in 1853 and headquartered in Vaughan, Canada. The company operates through three primary segments: Vision Care and Consumer Health Care, which includes contact lenses across all wearing modalities, lens care solutions, and over-the-counter eye care products; Ophthalmic Pharmaceuticals, offering both proprietary and generic medications for conditions such as glaucoma, ocular hypertension, and retinal diseases; and Surgical, which provides advanced surgical instruments, intraocular lenses, and equipment for cataract and retinal procedures. Together, these segments enable Bausch + Lomb to serve patients across the complete spectrum of eye health, from routine vision correction to complex surgical interventions.
